Navigation Links
Baseline characteristics of children with mild persistent asthma predict response to ICS
Date:5/22/2012

ATS 2012, SAN FRANCISCO A further analysis of a previously published National Heart, Lung, and Blood Institute (NHLBI) funded study of children with mild persistent asthma reports the relative benefits of inhaled corticosteroid (ICS) treatment varies among children with differing demographic and clinical characteristics.

"We performed post-hoc data analysis on 288 children enrolled in the TReating Children to Prevent Exacerbations of Asthma (TREXA) study performed by the NHLBI funded Childhood Asthma Research and Education (CARE) Network," said Lynn Gerald, PhD, MSPH, professor in the Department of Health Promotion Sciences and associate dean of research in the College of Public Health at the University of Arizona. "Our findings suggest that all children with mild persistent asthma benefit from ICS treatment, but some groups benefit more than others."

The TREXA trial compared four ICS treatment strategies: daily treatment (daily), daily treatment plus symptom-targeted treatment (combined), symptom-targeted only treatment (rescue), and placebo. Daily treatment, but not combined or rescue treatment, reduced the time to first exacerbation compared with placebo, and all three strategies reduced treatment failures. Time to treatment failure was defined as time to an oral corticosteroid-requiring exacerbation and treatment failure was defined as experiencing two or more oral corticosteroid-requiring exacerbations.

In post-hoc subgroup analyses using either time to first exacerbation or time to treatment failure as an outcome, children in the daily and combined groups who were younger (6-11 yrs versus 12-17 years), were non-Hispanic, had eczema, were skin test positive, and who had IgE levels >185K/uL experienced treatment benefit as compared to those assigned to placebo. Among children assigned to the rescue group, the results were similar to those above when using time to treatment failure as an outcome; however, when using time to first exacerbation as an outcome, only those with eczema, high IgE levels, and less than perfect asthma control during the run-in period were demonstrated to benefit when compared to placebo.

"Our study indicates that some groups of children with mild persistent asthma have greater exacerbation risk than others and therefore have more to gain from ICS treatment for reducing this risk," said Dr. Gerald. "These findings need to be validated in future studies."


'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. Baseline PSA predicts risk of death from prostate cancer
2. Early prostate cancer detection, screening: No benefit for men with low baseline PSA value
3. Does baseline concussion testing really reduce risks to athletes?
4. Validity of Baseline Concussion Tests Questioned
5. Concussion baseline important for accurate future assessment in at-risk youth athletes
6. Researchers find that sociodemographic characteristics are related to a patients willingness to participate in cancer screenings
7. Researchers report no difference in breast cancer characteristics after oophorectomy
8. Thesis investigates characteristics of society using sports activities as research tool
9. Why do risks with human characteristics make powerful consumers feel lucky?
10. New study helps clarify symptoms and characteristics of acid reflux in neonates
11. Pain characteristics suggest higher benefit from gallbladder surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill ... local company MitoXcell in preparation of the launch of her new book: Natalie Jill’s ... is a nutritional guide designed to jump start a new healthy lifestyle featuring simple ...
(Date:5/4/2016)... Durham, NC (PRWEB) , ... May 04, 2016 ... ... healthcare professionals in medical coding, billing and compliance. In upcoming months, AudioEducator has ... on various specialties. Every conference is designed to give complete compliance know-how and ...
(Date:5/4/2016)... Los Angeles, California (PRWEB) , ... May 04, 2016 , ... ... for Cancer Research (AACR) honors the month of May as National Cancer Research Month. ... to 1.6 million new diagnoses of cancer with predications of one in four Americans ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... that their Vasont Universal Integrator (VUI) extension supports the latest release of Adobe ... Adobe FrameMaker 2015 interlace the process of creating, editing and storing XML. ...
(Date:5/3/2016)... ... 2016 , ... ProIntro Glitch is a set of 30 self-animating glitch-themed intros ... users to add a terrifying opener to any video or media. Choose from unique ... add greater contrast, all the user has to do is increase the turn on ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... In March, 2016, Rx-360 ... free workshops across Africa ... Good Distribution Practices (GDP). Good Distribution Practice is ... are consistently stored, transported and handled under suitable conditions as ... Only a few years ago, there were few ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
Breaking Medicine Technology: